|
CA2371994C
(en)
*
|
1999-02-26 |
2010-09-28 |
Guido Grandi |
Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
|
|
CA2881568C
(en)
*
|
2000-10-27 |
2019-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from streptococcus groups a & b
|
|
US7082569B2
(en)
|
2001-01-17 |
2006-07-25 |
Outlooksoft Corporation |
Systems and methods providing dynamic spreadsheet functionality
|
|
SI1858920T1
(sl)
|
2005-02-18 |
2016-07-29 |
Glaxosmithkline Biologicals S.A. |
Proteini in nukleinske kisline iz escherichia coli, povezane z meningitisom/sepso
|
|
PE20110072A1
(es)
*
|
2005-06-27 |
2011-02-04 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica
|
|
EP2586790A3
(en)
|
2006-08-16 |
2013-08-14 |
Novartis AG |
Immunogens from uropathogenic Escherichia coli
|
|
ITMI20081249A1
(it)
*
|
2008-07-09 |
2010-01-09 |
Novartis Vaccines & Diagnostic |
Immunogeni di escherichia coli con solubilità migliorata.
|
|
JP5332237B2
(ja)
*
|
2008-03-06 |
2013-11-06 |
味の素株式会社 |
Ｌ−システイン生産菌及びｌ−システインの製造法
|
|
US8647642B2
(en)
|
2008-09-18 |
2014-02-11 |
Aviex Technologies, Llc |
Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
|
|
WO2010032138A2
(en)
|
2008-09-18 |
2010-03-25 |
Novartis Ag |
Vaccine adjuvant combinations
|
|
WO2010124085A2
(en)
*
|
2009-04-23 |
2010-10-28 |
Cornell University |
Compositions and methods for preventing and treating uterine disease
|
|
WO2010129578A1
(en)
*
|
2009-05-06 |
2010-11-11 |
Cornell Research Foundation, Inc. |
E. coli lpfa antigen for prevention and treatment of infectious diseases
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
WO2011008400A2
(en)
|
2009-06-16 |
2011-01-20 |
Novartis Ag |
High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
|
|
US10988511B2
(en)
*
|
2009-07-07 |
2021-04-27 |
Glaxosmithkline Biologicals Sa |
Conserved Escherichia bacterial IG-like domain (group 1) protein (ORF405) immunogens
|
|
AU2010272243A1
(en)
|
2009-07-16 |
2012-03-08 |
Novartis Ag |
Detoxified Escherichia coli immunogens
|
|
EP2277989A1
(en)
|
2009-07-24 |
2011-01-26 |
Technische Universiteit Delft |
Fermentative glycerol-free ethanol production
|
|
EP2470205A1
(en)
|
2009-08-27 |
2012-07-04 |
Novartis AG |
Adjuvant comprising aluminium, oligonucleotide and polycation
|
|
WO2011027222A2
(en)
|
2009-09-02 |
2011-03-10 |
Novartis Ag |
Immunogenic compositions including tlr activity modulators
|
|
EP2298798B1
(en)
*
|
2009-09-10 |
2012-05-09 |
Freie Universität Berlin |
Identification and characterization of a novel avian pathogenic E. coli (APEC) fimbrial adhesin
|
|
EP2482836B1
(en)
*
|
2009-10-02 |
2016-04-13 |
Oslo Universitetssykehus HF |
Antibacterial polypeptides and use thereof
|
|
US8741591B2
(en)
|
2009-10-09 |
2014-06-03 |
The Research Foundation For The State University Of New York |
pH-insensitive glucose indicator protein
|
|
JP5788404B2
(ja)
|
2009-12-11 |
2015-09-30 |
アウトイフオンイ トヘラペウトイクス リミテッド |
イミダゾリジンジオン誘導体
|
|
WO2011080595A2
(en)
|
2009-12-30 |
2011-07-07 |
Novartis Ag |
Polysaccharide immunogens conjugated to e. coli carrier proteins
|
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
|
ES2646669T3
(es)
|
2010-07-06 |
2017-12-14 |
Glaxosmithkline Biologicals Sa |
Procedimientos de aumento de una respuesta inmunitaria mediante el suministro de ARN
|
|
EP2591114B1
(en)
|
2010-07-06 |
2016-06-08 |
GlaxoSmithKline Biologicals SA |
Immunisation of large mammals with low doses of rna
|
|
MX342608B
(es)
|
2010-07-06 |
2016-10-06 |
Novartis Ag * |
Particulas de suministro similares a viriones para moleculas de arn de autorreplicacion.
|
|
ES2557382T3
(es)
|
2010-07-06 |
2016-01-25 |
Glaxosmithkline Biologicals Sa |
Liposomas con lípidos que tienen un valor de pKa ventajoso para el suministro de ARN
|
|
MX2013002332A
(es)
|
2010-08-31 |
2013-03-18 |
Novartis Ag |
Lipidos apropiados para suministro liposomal del arn que codifica la proteina.
|
|
LT4226941T
(lt)
|
2010-08-31 |
2025-01-10 |
Glaxosmithkline Biologicals Sa |
Pegilintos liposomos, skirtos imunogeną koduojančios rnr pristatymui
|
|
AU2011295853A1
(en)
|
2010-09-01 |
2013-04-04 |
Irm Llc |
Adsorption of immunopotentiators to insoluble metal salts
|
|
US9259462B2
(en)
*
|
2010-09-10 |
2016-02-16 |
Glaxosmithkline Biologicals Sa |
Developments in meningococcal outer membrane vesicles
|
|
WO2012051211A2
(en)
|
2010-10-11 |
2012-04-19 |
Novartis Ag |
Antigen delivery platforms
|
|
ES2630029T3
(es)
|
2010-12-14 |
2017-08-17 |
Glaxosmithkline Biologicals Sa |
Análisis de citometría de flujo de materiales adsorbidos en sales metálicas
|
|
EP2667852B1
(en)
|
2011-01-27 |
2016-11-09 |
GlaxoSmithKline Biologicals SA |
Adjuvant nanoemulsions with crystallisation inhibitors
|
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US10010568B2
(en)
|
2011-02-04 |
2018-07-03 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a spirochetes infection in a human being
|
|
US11357722B2
(en)
|
2011-02-04 |
2022-06-14 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US10512661B2
(en)
|
2011-02-04 |
2019-12-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US10548761B2
(en)
|
2011-02-04 |
2020-02-04 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
|
US12533312B2
(en)
|
2011-02-04 |
2026-01-27 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
|
US10111913B2
(en)
|
2011-02-04 |
2018-10-30 |
Joseph E. Kovarik |
Method of reducing the likelihood of skin cancer in an individual human being
|
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
|
US10086018B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US12257272B2
(en)
|
2015-12-24 |
2025-03-25 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US9987224B2
(en)
|
2011-02-04 |
2018-06-05 |
Joseph E. Kovarik |
Method and system for preventing migraine headaches, cluster headaches and dizziness
|
|
US11419903B2
(en)
|
2015-11-30 |
2022-08-23 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US10085938B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for preventing sore throat in humans
|
|
US10583033B2
(en)
|
2011-02-04 |
2020-03-10 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US10842834B2
(en)
|
2016-01-06 |
2020-11-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US10940169B2
(en)
|
2015-11-30 |
2021-03-09 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing cancer in an individual human being
|
|
US11273187B2
(en)
|
2015-11-30 |
2022-03-15 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing depression in an individual
|
|
US10687975B2
(en)
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
|
US10245288B2
(en)
|
2011-02-04 |
2019-04-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
|
|
US11191665B2
(en)
|
2011-02-04 |
2021-12-07 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US10835560B2
(en)
|
2013-12-20 |
2020-11-17 |
Joseph E. Kovarik |
Reducing the likelihood of skin cancer in an individual human being
|
|
US12279989B2
(en)
|
2011-02-04 |
2025-04-22 |
Seed Health, Inc. |
Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
|
|
WO2012117377A1
(en)
|
2011-03-02 |
2012-09-07 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
WO2012129483A1
(en)
|
2011-03-24 |
2012-09-27 |
Novartis Ag |
Adjuvant nanoemulsions with phospholipids
|
|
EP4115875A1
(en)
|
2011-07-06 |
2023-01-11 |
GlaxoSmithKline Biologicals S.A. |
Liposomes having useful n:p ratio for delivery of rna molecules
|
|
EP2729165B1
(en)
|
2011-07-06 |
2017-11-08 |
GlaxoSmithKline Biologicals SA |
Immunogenic combination compositions and uses thereof
|
|
MX366055B
(es)
|
2011-08-31 |
2019-06-26 |
Novartis Ag |
Liposomas pegilados para admistracion de acido ribonucleico (arn) que codifica para inmunogeno.
|
|
EP2755994A2
(en)
|
2011-09-14 |
2014-07-23 |
Novartis AG |
Escherichia coli vaccine combination
|
|
KR101359844B1
(ko)
*
|
2012-01-06 |
2014-02-25 |
씨제이제일제당 (주) |
퀴놀린산을 생산하는 재조합 미생물 및 이를 이용한 퀴놀린산의 생산 방법
|
|
EP2806026B1
(en)
*
|
2012-01-18 |
2018-12-26 |
Mitsui Chemicals, Inc. |
Method for producing 1,5-pentamethylenediamine, mutant lysine decarboxylase, method for producing 1,5-pentamethylene diisocyanate and method for producing polyisocyanate composition
|
|
SI2822947T1
(sl)
|
2012-03-07 |
2016-10-28 |
Glaxosmithkline Biologicals S.A. |
Argininske soli TLR7 agonista
|
|
JP2015510872A
(ja)
|
2012-03-07 |
2015-04-13 |
ノバルティス アーゲー |
Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
|
|
MX372965B
(es)
|
2012-03-08 |
2020-04-01 |
Glaxosmithkline Biologicals Sa |
Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo.
|
|
WO2014014207A1
(en)
*
|
2012-07-20 |
2014-01-23 |
University-Industry Cooperation Group Of Kyung Hee University |
Antibody for epitope tagging, hybridoma cell line and uses thereof
|
|
JP6283674B2
(ja)
|
2012-09-18 |
2018-02-21 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
外膜小胞
|
|
CA2886748A1
(en)
*
|
2012-10-17 |
2014-04-24 |
Enterome |
Gene signatures of inflammatory disorders that relate to the liver
|
|
US10288610B2
(en)
*
|
2012-11-13 |
2019-05-14 |
The General Hospital Corporation |
Vitro assays for detecting Salmonella enterica serotype typhi
|
|
WO2014102694A1
(en)
|
2012-12-24 |
2014-07-03 |
Novartis Ag |
Novel mucinase for use in therapy or prophylaxis
|
|
CN107879960B
(zh)
|
2013-03-08 |
2021-06-22 |
诺华股份有限公司 |
用于传递活性成分的脂质和脂质组合物
|
|
CN112301024A
(zh)
|
2013-03-15 |
2021-02-02 |
通用医疗公司 |
使用RNA引导的FokI核酸酶(RFN)提高RNA引导的基因组编辑的特异性
|
|
WO2014204578A1
(en)
|
2013-06-21 |
2014-12-24 |
The General Hospital Corporation |
Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
|
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
|
KR101525663B1
(ko)
*
|
2013-05-10 |
2015-06-04 |
씨제이제일제당 (주) |
신규 ｏ-포스포세린 배출 단백질 및 이를 이용한 ｏ-포스포세린의 생산방법
|
|
US11274144B2
(en)
|
2013-06-13 |
2022-03-15 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
US10195257B2
(en)
*
|
2013-07-28 |
2019-02-05 |
Qantu Therapeutics, Inc. |
Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response
|
|
KR20150018227A
(ko)
*
|
2013-08-09 |
2015-02-23 |
삼성전자주식회사 |
외인성 푸마라아제 유전자를 포함하는 코리네박테리움 및 이를 이용한 c4 디카르복실산의 생산 방법
|
|
US11248040B2
(en)
|
2013-09-26 |
2022-02-15 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
EP3083556B1
(en)
|
2013-12-19 |
2019-12-25 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
US10426737B2
(en)
|
2013-12-19 |
2019-10-01 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
US12246043B2
(en)
|
2013-12-20 |
2025-03-11 |
Seed Health, Inc. |
Topical application to treat acne vulgaris
|
|
US11529379B2
(en)
|
2013-12-20 |
2022-12-20 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
|
|
US11026982B2
(en)
|
2015-11-30 |
2021-06-08 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
|
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
|
US12329783B2
(en)
|
2013-12-20 |
2025-06-17 |
Seed Health, Inc. |
Method and system to improve the health of a person's skin microbiome
|
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
|
US11642382B2
(en)
|
2013-12-20 |
2023-05-09 |
Seed Health, Inc. |
Method for treating an individual suffering from bladder cancer
|
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
|
US11672835B2
(en)
|
2013-12-20 |
2023-06-13 |
Seed Health, Inc. |
Method for treating individuals having cancer and who are receiving cancer immunotherapy
|
|
US11213552B2
(en)
|
2015-11-30 |
2022-01-04 |
Joseph E. Kovarik |
Method for treating an individual suffering from a chronic infectious disease and cancer
|
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
|
US12318377B2
(en)
|
2013-12-20 |
2025-06-03 |
Seed Health, Inc. |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
|
US10624934B2
(en)
*
|
2014-03-06 |
2020-04-21 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations
|
|
JP6754694B2
(ja)
*
|
2014-03-06 |
2020-09-16 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
プロバイオティクス製剤および使用のための方法
|
|
CL2014001126A1
(es)
*
|
2014-04-29 |
2014-08-29 |
Univ Chile |
Composición farmacéutica útil como vacuna contra bacterias escherichia coli productoras de shigatoxinas (stec), que comprende al menos un antígeno o una proteína de membrana externa inmunogénica o proteína inmunogénica asociada y conservada en cepas stec.
|
|
CN106794141B
(zh)
|
2014-07-16 |
2021-05-28 |
诺华股份有限公司 |
将核酸包封在脂质纳米粒主体中的方法
|
|
US10125092B2
(en)
|
2014-09-05 |
2018-11-13 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
EP3061826A1
(en)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus replicons
|
|
ES2811337T3
(es)
*
|
2015-04-07 |
2021-03-11 |
Metabolic Explorer Sa |
Microorganismo modificado para la producción optimizada de 2,4-dihidroxibutirato con eflujo de 2,4- dihidroxibutirato aumentado
|
|
US20160317615A1
(en)
*
|
2015-05-01 |
2016-11-03 |
Jose Javier Lopez GONZALEZ |
T cell modulator
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11209972B2
(en)
|
2015-09-02 |
2021-12-28 |
D&M Holdings, Inc. |
Combined tablet screen drag-and-drop interface
|
|
WO2016210384A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
WO2017023863A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
EP3365027B1
(en)
|
2015-10-14 |
2022-03-30 |
Research Institute at Nationwide Children's Hospital |
Hu specific antibodies and their use in inhibiting biofilm
|
|
WO2017086329A1
(ja)
*
|
2015-11-16 |
2017-05-26 |
国立大学法人熊本大学 |
細胞の再プログラミングを誘導する組成物、及び該組成物を用いた多能性細胞の製造方法
|
|
US11529412B2
(en)
|
2015-11-30 |
2022-12-20 |
Seed Health, Inc. |
Method and system for protecting honey bees from pesticides
|
|
US10568916B2
(en)
|
2015-11-30 |
2020-02-25 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
|
US10086024B2
(en)
|
2015-11-30 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
|
US12239706B2
(en)
|
2015-11-30 |
2025-03-04 |
Seed Health, Inc. |
Method and system for protecting monarch butterflies from pesticides
|
|
US10933128B2
(en)
|
2015-11-30 |
2021-03-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees from pesticides
|
|
US10675347B2
(en)
|
2015-11-30 |
2020-06-09 |
Joseph E. Kovarik |
Method and system for protecting honey bees from fipronil pesticides
|
|
JP7523776B2
(ja)
*
|
2016-01-21 |
2024-07-29 |
ティー２ バイオシステムズ，インコーポレーテッド |
細菌を迅速に検出するｎｍｒ法及びシステム
|
|
CN109310730A
(zh)
*
|
2016-02-17 |
2019-02-05 |
佩普蒂康姆有限责任公司 |
Tlr4活化的肽激动剂和拮抗剂
|
|
WO2017160779A2
(en)
*
|
2016-03-14 |
2017-09-21 |
The Translational Genomics Research Institute |
Methods and kits to identify klebsiella strains
|
|
CN108884483A
(zh)
*
|
2016-03-16 |
2018-11-23 |
帝斯曼知识产权资产管理有限公司 |
烟酸核糖苷的微生物生产
|
|
KR102253900B1
(ko)
*
|
2016-04-27 |
2021-05-18 |
바이오셀즈(베이징) 바이오테크 코., 엘티디. |
흥분성 신경독성 관련 손상 치료용 펩타이드
|
|
GB201617548D0
(en)
*
|
2016-10-17 |
2016-11-30 |
Linnane Pharma Ab |
Novel biological factor
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
CN110366428B
(zh)
|
2016-12-30 |
2024-05-17 |
Vaxcyte公司 |
具有非天然氨基酸的多肽-抗原缀合物
|
|
JP7661008B2
(ja)
|
2017-01-04 |
2025-04-14 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
バイオフィルム関連障害の処置のための抗体断片
|
|
US11564982B2
(en)
|
2017-01-04 |
2023-01-31 |
Research Institute At Nationwide Children's Hospital |
DNABII vaccines and antibodies with enhanced activity
|
|
US11421235B2
(en)
|
2017-04-28 |
2022-08-23 |
Precigen, Inc. |
Methods and microorganisms for the fermentation of methane to multi-carbon compounds
|
|
KR101943081B1
(ko)
*
|
2017-08-31 |
2019-01-29 |
(주)케어젠 |
주름 개선 활성을 나타내는 펩타이드 및 이의 용도
|
|
WO2019147743A1
(en)
|
2018-01-26 |
2019-08-01 |
Massachusetts Institute Of Technology |
Structure-guided chemical modification of guide rna and its applications
|
|
EP3821026A4
(en)
|
2018-07-09 |
2022-06-01 |
Codexis, Inc. |
MANIPULATED ENZYME VARIANTS OF PHOSPHOPENTOMUTASE
|
|
WO2020055547A2
(en)
|
2018-08-18 |
2020-03-19 |
Seed Health, Inc. |
Methods and compositions for honey bee health
|
|
CN112771074A
(zh)
|
2018-10-05 |
2021-05-07 |
国家儿童医院研究所 |
用于酶促破坏细菌生物膜的组合物和方法
|
|
AU2019354829B2
(en)
|
2018-10-05 |
2025-04-17 |
Research Institute At Nationwide Children's Hospital |
Hmgb1 protein derivatives for the removal of biofilms
|
|
EP3870154A4
(en)
|
2018-10-22 |
2022-07-27 |
Research Institute at Nationwide Children's Hospital |
COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ANTIBIOTIC-INDUCED PATHOLOGIES USING PROBIOTICS IN BIOFILM STATE
|
|
KR101996767B1
(ko)
*
|
2018-11-29 |
2019-07-04 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
KR101991206B1
(ko)
*
|
2018-11-29 |
2019-06-19 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
KR101991207B1
(ko)
|
2018-11-29 |
2019-06-19 |
씨제이제일제당 (주) |
cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법
|
|
WO2020117715A1
(en)
|
2018-12-03 |
2020-06-11 |
Board Of Regents, The University Of Texas System |
Oligo-benzamide analogs and their use in cancer treatment
|
|
US20220031862A1
(en)
*
|
2018-12-10 |
2022-02-03 |
Flagship Pioneering Innovations Vi, Llc |
Achromosomal dynamic active systems
|
|
WO2020234498A2
(es)
*
|
2019-05-15 |
2020-11-26 |
Universidad De Granada |
Terapia génica con los genes hokd y ldrb para el tratamiento del cáncer
|
|
EP3979830B1
(en)
|
2019-06-03 |
2025-11-26 |
Research Institute at Nationwide Children's Hospital |
Formulations for the treatment of neurodevelopmental deficiencies induced by necrotizing enterocolitis
|
|
WO2020257395A1
(en)
*
|
2019-06-21 |
2020-12-24 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli
|
|
CN110441284B
(zh)
*
|
2019-07-23 |
2022-02-15 |
海南大学 |
一种可用于痕量检测的表面增强拉曼散射芯片的制备方法及所得产品和应用
|
|
KR102183209B1
(ko)
*
|
2019-09-09 |
2020-11-26 |
씨제이제일제당 주식회사 |
L-쓰레오닌 배출 단백질의 변이체 및 이를 이용한 l-쓰레오닌 생산 방법
|
|
JP7735863B2
(ja)
*
|
2019-10-28 |
2025-09-09 |
味の素株式会社 |
ベンズアルデヒドの製造方法
|
|
US20230041211A1
(en)
*
|
2019-12-20 |
2023-02-09 |
Basf Se |
Decreasing toxicity of terpenes and increasing the production potential in micro-organisms
|
|
US20230105474A1
(en)
*
|
2020-02-25 |
2023-04-06 |
Synlogic Operating Company, Inc. |
Recombinant bacteria engineered to treat diseases associated with uric acid and methods of use thereof
|
|
CN111778224B
(zh)
*
|
2020-07-20 |
2021-06-01 |
成都薇合生物科技有限公司 |
尿酸酶或其同源酶及其应用
|
|
CN116897205A
(zh)
*
|
2020-08-28 |
2023-10-17 |
科德克希思公司 |
工程化淀粉酶变体
|
|
EP4225909A4
(en)
*
|
2020-10-07 |
2025-02-12 |
Codexis, Inc. |
Engineered phosphopentomutase variant enzymes
|
|
CN112391331B
(zh)
*
|
2020-11-12 |
2022-09-27 |
江南大学 |
一种过表达GatA基因的重组大肠杆菌及其应用
|
|
KR102792504B1
(ko)
*
|
2020-12-28 |
2025-04-09 |
대상 주식회사 |
히스티딘에 의한 피드백 억제가 감소된 atp-prt 변이체 및 이를 발현하는 히스티딘 생산 균주
|
|
CN114137209B
(zh)
*
|
2021-02-01 |
2024-03-01 |
中国水产科学研究院黄海水产研究所 |
一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用
|
|
US11452757B2
(en)
*
|
2021-02-25 |
2022-09-27 |
Intron Biotechnology, Inc. |
Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
|
|
IL307247A
(en)
|
2021-04-01 |
2023-11-01 |
Janssen Pharmaceuticals Inc |
Production of E. Coli O18 bioconjugates
|
|
KR102707457B1
(ko)
*
|
2021-06-11 |
2024-09-20 |
씨제이제일제당 주식회사 |
신규한 MdtH 변이체 및 이를 이용한 O-포스포세린, 시스테인 및 이의 유도체의 생산방법
|
|
US20240350410A1
(en)
|
2021-08-16 |
2024-10-24 |
Glaxosmithkline Biologicals Sa |
Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof
|
|
EP4387596A1
(en)
|
2021-08-16 |
2024-06-26 |
GlaxoSmithKline Biologicals SA |
Low-dose lyophilized rna vaccines and methods for preparing and using the same
|
|
US20250137050A1
(en)
*
|
2021-08-18 |
2025-05-01 |
The Regents Of The University Of California |
Methods and compositions for determining risk of autism spectrum disorders
|
|
CN113897324B
(zh)
*
|
2021-10-13 |
2023-07-28 |
云南师范大学 |
一种用作抗锰剂的JcVIPP1重组大肠杆菌及其构建方法
|
|
CN114107413B
(zh)
*
|
2021-11-03 |
2023-10-20 |
江苏香地化学有限公司 |
一种酶催化胞嘧啶生产胞苷的方法及应用
|
|
US11548917B1
(en)
*
|
2021-11-24 |
2023-01-10 |
Intron Biotechnology, Inc. |
Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
|
|
JP7684523B2
(ja)
*
|
2021-12-21 |
2025-05-27 |
エスアールアイ インターナショナル |
中枢神経系への細胞特異的輸送のための二重標的化
|
|
CN114522230A
(zh)
*
|
2022-01-11 |
2022-05-24 |
上海市伤骨科研究所 |
一种蓝光和对苯醌联合杀菌方法
|
|
WO2023139605A1
(en)
*
|
2022-01-20 |
2023-07-27 |
Techinvention Lifecare Pvt. Ltd. |
Lysin polypeptides and compositions thereof against urinary tract infection caused by drug-resistant gram- negative bacteria
|
|
CN115286701A
(zh)
*
|
2022-03-07 |
2022-11-04 |
江苏靶标生物医药研究所有限公司 |
一种调节哺乳动物的肠道粘膜稳态或炎症性肠病的靶点及其应用
|
|
US20240003886A1
(en)
*
|
2022-06-15 |
2024-01-04 |
Quantum-Si Incorporated |
Directed protein evolution
|
|
WO2024073730A2
(en)
*
|
2022-09-29 |
2024-04-04 |
The University Of Chicago |
Methods and systems for rna sequencing and analysis
|
|
JP2025538284A
(ja)
|
2022-10-19 |
2025-11-27 |
グライプロバック アプス |
尿路病原性Ｅ．コリ（Ｅ．ｃｏｌｉ）からのグリコシル化ＹＧＨＪポリペプチド
|
|
CN118086235A
(zh)
*
|
2022-11-28 |
2024-05-28 |
宁波酶赛生物工程有限公司 |
一种合成d-泛解酸的酶催化剂和方法
|
|
KR102921214B1
(ko)
*
|
2023-01-31 |
2026-02-03 |
대상 주식회사 |
망가니즈 익스포터 신규 변이체 및 이를 이용한 l-히스티딘 생산 방법
|
|
GB202303019D0
(en)
|
2023-03-01 |
2023-04-12 |
Glaxosmithkline Biologicals Sa |
Method of lyophilisation
|
|
WO2025017339A1
(en)
*
|
2023-07-14 |
2025-01-23 |
Iowa State University Research Foundation, Inc. |
Escherichia coli nhaa membrane protein drug target and immunogenic compositions therefrom
|
|
CN116949027B
(zh)
*
|
2023-07-19 |
2024-12-24 |
浙江中医药大学 |
一种尿路致病性大肠埃希菌重组蛋白组合物ls、其构建、表达、纯化方法及其应用
|
|
GB202311382D0
(en)
|
2023-07-25 |
2023-09-06 |
Glaxosmithkline Biologicals Sa |
Lyophilised compostion
|
|
WO2025219177A1
(en)
|
2024-04-18 |
2025-10-23 |
Glyprovac Aps |
Optimized plasmids for expression of yghj polypeptides
|
|
CN118388664B
(zh)
*
|
2024-05-21 |
2024-12-03 |
广东省农业科学院动物卫生研究所 |
副猪嗜血杆菌融合抗原及其应用
|
|
WO2026033498A1
(en)
|
2024-08-09 |
2026-02-12 |
Genvax Technologies, Inc. |
Methods of self-amplifying rna-lipid nanoparticle manufacture and compositions derived therefrom
|
|
CN119061031A
(zh)
*
|
2024-10-08 |
2024-12-03 |
安徽农业大学 |
一种水稻抗除草剂突变基因及其应用
|